TPO and thrombocytosis disease: We are hopeful that the coming few years will bring further insight into TPO signaling, particularly from a structural viewpoint, which could inform more targeted approaches in the design of therapeutics to treat thrombocytosis and other hematological disorders driven by abnormal TPO signaling.